Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients

NCT04480411 | Withdrawn

• 1 other identifier: 56472
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to assess the use of technology including remote vital sign monitoring in improving quality of patient care, decreasing hospital admissions and re-admissions, decreasing hospital length of stay and decreasing use of personal protective equipment.

Conditions

Diagnoses Disease; Covid19

Keywords

Telemedicine

Outcome Measures

Primary Outcomes (4)

• Patient provider experience survey score

  Five questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 5 (higher scores = better experience).

  Once after completion of device use (up to 15 minutes to complete the survey)

• Provider experience survey score

  Four questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 4 (higher scores = better experience).

  Once after completion of device use (up to 15 minutes to complete the survey)

• Use of personal protective improvement

  Level of personal protective improvement in an in-patient setting.

  6 months

• Number of in-patient encounters with COVID patients as a measure of provider exposure to high risk illness

  6 months

Study Arms (1)

COVID-19 Patients

EXPERIMENTAL

Patients that are admitted to the hospital with COVID 19.

Behavioral: Doctorgram Patient Kit

Interventions

Doctorgram Patient Kit BEHAVIORAL

Participants will use the Doctorgram Patient Kit for remote monitoring and remote use stethoscope.

COVID-19 Patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Hospitalized patient with COVID 19 or outpatient under investigation for or diagnosed with COVID 19
• Clinically stable (on 4L O2 or less, non ICU)
• Demonstrates ability to be trained in use of digital stethoscope technology

You may not qualify if:

• Pregnancy
• Delirium

Sponsors & Collaborators

• Stanford University: lead

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Ritu Parikh, MD

  Stanford University

  PRINCIPAL INVESTIGATOR

• Julieta M Gabiola, MD

  Stanford University

  PRINCIPAL INVESTIGATOR

• Nicholas Scoulios, MD

  Stanford University

  PRINCIPAL INVESTIGATOR

• Lisa Shieh, MD

  Stanford University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 17, 2020
• First Posted: July 21, 2020
• Study Start: January 1, 2022
• Primary Completion: December 1, 2022
• Study Completion: December 1, 2022
• Last Updated: January 31, 2022

Record last verified: 2022-01

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)